GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

The differential diagnosis of malignant melanoma includes atypical nevi, dermatofibromas, lentigos, basal cell carcinoma (especially ... nuclear medicine, and pathology, depending on tumor ...

Advancements in genetics and neuroimaging are unraveling how our DNA shapes the structure and function of the brain. Recent ...

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering hundreds of diseases, drugs, and markets and 11 integrated data sets that span ...

The basal ganglia are complex brain nuclei with excitatory ... The involvement of different brain regions and cell types indicates that the pathology implicates more than dopamine production. Critical ...

As a result, this will help to establish a more precise estimate of corneal nerve parameters for future research to use as a reference for identifying corneal nerve pathology ... sub-basal nerve ...

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone ...

Iowa State University scientists have made a significant breakthrough in scientists' ability to identify specific proteins ...